GCB News

Spanning Duke University and Duke Health, the Center for Advanced Genomic Technologies will use homegrown tools and techniques to discover potential therapies for human diseases from autism to cancer to schizophrenia.

If you asked Jenny Tung’s parents, “no one’s kids that they knew of went off to Africa every summer to look at monkeys.” But Tung has been doing just that since her first trip to Kenya in 2006 to study the wild baboons of Amboseli.

If you asked Jenny Tung’s parents, “no one’s kids that they knew of went off to Africa every summer to look at monkeys.” But Tung has been doing just that since her first trip to Kenya in 2006 to study the wild baboons of Amboseli.

In a new study, Charlie Gersbach describes how he successfully harnessed Class 1 CRISPR systems to turn target genes on and off and edit the epigenome in human cells for the first time.

The biomanufacturing platform uses bursting bacteria and a shrinking capsule to produce targeted proteins.

Xiling Shen principal investigator in new DARPA project.

Here are summaries of a selection of the papers published by GCB faculty in August 2019:

Banned painkiller had a unique effect on the model fish, so they shifted focus to figure out why.

Here are summaries of a selection of the papers published by GCB faculty in July 2019:

DISEASE

Genome-wide association studies have discovered multiple single nucleotide polymorphisms (SNPS) associated with late-onset Alzheimer's disease (LOAD); however, the actual causal genes have not yet been identified. Ornit Chiba-Falek and team used a new computational strategy to identify causal genes for LOAD and to guide further laboratory experiments. Read more

Early studies suggest restricting an amino acid works similarly to chemotherapy, radiation.